Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice.

Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice.

Inflammatory bowel disease is a chronic gastrointestinal inflammatory disorder associated with changes in neuropeptide expression and function, including vasoactive intestinal peptide (VIP). VIP regulates intestinal vasomotor and secretomotor function and motility; however, VIP's role in develo...

Full description

Bibliographic Details
Main Authors:	Xiujuan Wu, Victoria S Conlin, Vijay Morampudi, Natasha R Ryz, Yasmin Nasser, Ganive Bhinder, Kirk S Bergstrom, Hong B Yu, Chris C M Waterhouse, Allison M J Buchan, Oana E Popescu, William T Gibson, James A Waschek, Bruce A Vallance, Kevan Jacobson
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4416880?pdf=render

Similar Items

The Microbiota Conducts the Vasoactive Intestinal Polypeptide Orchestra in the Small Intestine
by: Jacques Gonzales, et al.
Published: (2024-01-01)

Goblet Cell Derived RELM-β Recruits CD4+ T Cells during Infectious Colitis to Promote Protective Intestinal Epithelial Cell Proliferation.
by: Kirk S B Bergstrom, et al.
Published: (2015-08-01)

Vasoactive Intestinal Polypeptide (VIP) in the Intestinal Mucosal Nerve Fibers in Dogs with Inflammatory Bowel Disease
by: Andrzej Rychlik, et al.
Published: (2020-09-01)

Vasoactive Intestinal Polypeptide Plays a Key Role in the Microbial-Neuroimmune Control of Intestinal MotilitySummary
by: Xiaopeng Bai, et al.
Published: (2024-01-01)

Vasoactive intestinal polypeptide level in gastroesophageal reflux disease before and after surgical treatment
by: Ye. I. Haidarzhi, et al.
Published: (2023-07-01)

A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2
by: Yingna Xu, et al.
Published: (2022-04-01)

Dose-dependent effects of vasoactive intestinal polypeptide on somatostatin release from hypothalamic fragments in vitro.
by: Lengyel, A, et al.
Published: (1989)

Parvalbumin- and vasoactive intestinal polypeptide-expressing neocortical interneurons impose differential inhibition on Martinotti cells
by: F. Walker, et al.
Published: (2016-11-01)

Vasoactive Intestinal Polypeptide in the Carotid Body—A History of Forty Years of Research. A Mini Review
by: Slawomir Gonkowski
Published: (2020-06-01)

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases
by: Irene Solés-Tarrés, et al.
Published: (2020-07-01)

Changes in vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide and neuropeptide Y-ergic structures of the enteric nervous system in the carcinoma of the human large intestine.
by: Ireneusz Mirosław Łakomy, et al.
Published: (2010-08-01)

Vasoactive intestinal peptide–VIPR2 signaling regulates tumor cell migration
by: Satoshi Asano, et al.
Published: (2022-09-01)

The Impact of T-2 Toxin on Vasoactive Intestinal Polypeptide-Like Immunoreactive (VIP-LI) Nerve Structures in the Wall of the Porcine Stomach and Duodenum
by: Krystyna Makowska, et al.
Published: (2018-03-01)

Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor
by: Oana Belei, et al.
Published: (2023-09-01)

The G Protein-Coupled Receptor, VPAC1, Mediates Vasoactive Intestinal Peptide-Dependent Functional Homeostasis of the Gut Microbiota
by: Aaron C. Ericsson, et al.
Published: (2022-01-01)

Localization of Vasoactive Intestinal Polypeptide Receptor 1 (VPAC1) in Hypothalamic Neuroendocrine Oxytocin Neurons; A Potential Role in Circadian Prolactin Secretion
by: Ida Stangerup, et al.
Published: (2020-10-01)

Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson’s Disease
by: Shiyu Hu, et al.
Published: (2021-09-01)

Editorial: Novel Therapeutic Potential for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), Vasoactive Intestinal Peptide (VIP) and Related Peptides in Cognition Deficits
by: Lucia Ciranna, et al.
Published: (2021-09-01)

Vasoactive Intestinal Peptide Deficiency Is Associated With Altered Gut Microbiota Communities in Male and Female C57BL/6 Mice
by: Manpreet Bains, et al.
Published: (2019-12-01)

Therapeutic effect of vasoactive intestinal peptide in collagen-induced arthritis.
by: Williams, R
Published: (2002)

Immunomodulatory role of vasoactive intestinal peptide and ghrelin in Oncorhynchus mykiss
by: Carolina Muñoz-Flores, et al.
Published: (2023-12-01)

Involvement of Vasoactive Intestinal Peptide Family Members in Diabetic Keratopathy
by: Grazia Maugeri, et al.
Published: (2024-02-01)

Role of vasoactive intestinal peptide in Aspergillus fumigatus-infected cornea
by: Cui Li, et al.
Published: (2018-02-01)

The Neuropeptides Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Control HIV-1 Infection in Macrophages Through Activation of Protein Kinases A and C
by: Jairo R. Temerozo, et al.
Published: (2018-06-01)

Pressure-Dependent Elevation of Vasoactive Intestinal Peptide Level in Chicken Choroid
by: Evgeny Privalov, et al.
Published: (2023-03-01)

Effect of vasoactive intestinal peptide on the wound healing of alkali-burned corneas
by: Nese Tuncel, et al.
Published: (2016-02-01)

Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens
by: Bo Li, et al.
Published: (2019-08-01)

Vasoactive intestinal peptide in canine portosystemic shunt in the absence of portal hypertension
by: Mitsuhiro Isaka, et al.
Published: (2021-01-01)

Vasoactive intestinal peptide regulates ileal goblet cell production in mice
by: Luke A. Schwerdtfeger, et al.
Published: (2020-02-01)

Evaluation of Serum Levels of Transient Receptor Potential Cation Channel Subfamily V Member 1, Vasoactive Intestinal Polypeptide, and Pituitary Adenylate Cyclase-Activating Polypeptide in Chronic and Episodic Migraine: The Possible Role in Migraine Transformation
by: Mansoureh Togha, et al.
Published: (2021-12-01)

Effects of Vasoactive Intestinal Polypeptide and Forskolin on mRNA Expression of Prolactin and Prolactin Regulatory Element-Binding Protein in the Anterior Pituitary Gland of Chicken Embryo and Laying Hens
by: Norio Kansaku, et al.
Published: (2016-10-01)

Localization of the neuropeptides pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal peptide, and their receptors in the basal brain blood vessels and trigeminal ganglion of the mouse CNS; an immunohistochemical study
by: Anne Marie Lund, et al.
Published: (2022-10-01)

Effect of Acrylamide Supplementation on the Population of Vasoactive Intestinal Peptide (VIP)-Like Immunoreactive Neurons in the Porcine Small Intestine
by: Katarzyna Palus, et al.
Published: (2020-12-01)

The role of vasoactive intestinal peptide (VIP) in atropine-related inhibition of the progression of myopia
by: Ying Wang, et al.
Published: (2024-01-01)

Serum levels of vasoactive intestinal peptide as a prognostic marker in early arthritis.
by: Carmen Martínez, et al.
Published: (2014-01-01)

Non-specific activation of human eosinophil functional responses by vasoactive intestinal peptide
by: Amr El-Shazly, et al.
Published: (2000-01-01)

Vasoactive Intestinal Peptide-Secreting Pheochromocytoma: A Case Report and Review of Literature
by: Shelby K. Yee, et al.
Published: (2022-07-01)

Serum substance P and vasoactive intestinal peptide levels in infants with acute intussusception
by: Zhen-chuang Zhu, et al.
Published: (2019-06-01)

Role of Vasoactive Intestinal Peptide in Promoting the Pathogenesis of Eosinophilic Esophagitis (EoE)
by: Alok K. Verma, et al.
Published: (2018-01-01)

Expression of vasoactive intestinal polypeptide, substance P and neuropeptide Y in jejunal enteric nerves is altered in rabbits suffering from long term Trichinella spiralis infection: an immunohistochemical study
by: M.B. Arciszewski, et al.
Published: (2009-12-01)